State Street’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$881K Buy
290,907
+207,707
+250% +$629K ﹤0.01% 3512
2025
Q1
$354K Buy
83,200
+1,000
+1% +$4.26K ﹤0.01% 3683
2024
Q4
$434K Buy
82,200
+55,600
+209% +$294K ﹤0.01% 3653
2024
Q3
$48.7K Hold
26,600
﹤0.01% 4108
2024
Q2
$55.3K Hold
26,600
﹤0.01% 4125
2024
Q1
$107K Sell
26,600
-4,300
-14% -$17.2K ﹤0.01% 4021
2023
Q4
$57.8K Hold
30,900
﹤0.01% 4172
2023
Q3
$51.6K Hold
30,900
﹤0.01% 4281
2023
Q2
$73.9K Hold
30,900
﹤0.01% 4303
2023
Q1
$95.8K Hold
30,900
﹤0.01% 4338
2022
Q4
$82.8K Hold
30,900
﹤0.01% 4427
2022
Q3
$91K Hold
30,900
﹤0.01% 4495
2022
Q2
$91K Hold
30,900
﹤0.01% 4565
2022
Q1
$158K Buy
30,900
+1,100
+4% +$5.63K ﹤0.01% 4471
2021
Q4
$201K Buy
29,800
+7,000
+31% +$47.2K ﹤0.01% 4351
2021
Q3
$158K Buy
22,800
+12,441
+120% +$86.2K ﹤0.01% 4431
2021
Q2
$101K Sell
10,359
-49,774
-83% -$485K ﹤0.01% 4365
2021
Q1
$946K Buy
60,133
+10,100
+20% +$159K ﹤0.01% 3632
2020
Q4
$1.21M Buy
50,033
+27,015
+117% +$654K ﹤0.01% 3526
2020
Q3
$387K Buy
23,018
+4,861
+27% +$81.7K ﹤0.01% 3599
2020
Q2
$532K Buy
+18,157
New +$532K ﹤0.01% 3535
2016
Q2
Sell
-2,361
Closed -$729K 3762
2016
Q1
$729K Buy
2,361
+874
+59% +$270K ﹤0.01% 3285
2015
Q4
$924K Buy
1,487
+123
+9% +$76.4K ﹤0.01% 3223
2015
Q3
$758K Buy
1,364
+183
+15% +$102K ﹤0.01% 3260
2015
Q2
$844K Buy
+1,181
New +$844K ﹤0.01% 3280